144 related articles for article (PubMed ID: 35249899)
1. Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
Jojima T; Shinzawa T; Ohira E; Sakurai S; Tomaru T; Iijima T; Kogai T; Usui I; Aso Y
Endocr J; 2022 Aug; 69(8):941-945. PubMed ID: 35249899
[TBL] [Abstract][Full Text] [Related]
2. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
3. Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.
Ferrari SM; Patrizio A; Mazzi V; Ragusa F; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Bracchitta F; Stoppini G; Frenzilli G; Baldini E; Virili C; Benvenga S; Fallahi P; Antonelli A
Front Endocrinol (Lausanne); 2024; 15():1386510. PubMed ID: 38665263
[TBL] [Abstract][Full Text] [Related]
4. Switch from tablet levothyroxine to oral solution resolved reduced absorption by intestinal parasitosis.
Tortora A; La Sala D; Vitale M
Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30897550
[TBL] [Abstract][Full Text] [Related]
5. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
6. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
7. Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine.
Cellini M; Santaguida MG; Gatto I; Virili C; Del Duca SC; Brusca N; Capriello S; Gargano L; Centanni M
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1454-8. PubMed ID: 24796930
[TBL] [Abstract][Full Text] [Related]
8. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
9. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
[TBL] [Abstract][Full Text] [Related]
10. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
Benvenga S; Di Bari F; Vita R
Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
[TBL] [Abstract][Full Text] [Related]
11. Unawareness of the effects of soy intake on the management of congenital hypothyroidism.
Fruzza AG; Demeterco-Berggren C; Jones KL
Pediatrics; 2012 Sep; 130(3):e699-702. PubMed ID: 22908106
[TBL] [Abstract][Full Text] [Related]
12. Utility of a Liquid Formulation of Levo-thyroxine in Differentiated Thyroid Cancer Patients.
Giusti M; Mortara L; Machello N; Monti E; Pera G; Marenzana M
Drug Res (Stuttg); 2015 Jun; 65(6):332-6. PubMed ID: 25020105
[TBL] [Abstract][Full Text] [Related]
13. Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule.
Vita R; Benvenga S
Endocr Pract; 2014 Mar; 20(3):e38-41. PubMed ID: 24246350
[TBL] [Abstract][Full Text] [Related]
14. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer.
Burmeister LA; Goumaz MO; Mariash CN; Oppenheimer JH
J Clin Endocrinol Metab; 1992 Aug; 75(2):344-50. PubMed ID: 1639933
[TBL] [Abstract][Full Text] [Related]
15. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
16. Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine.
Fallahi P; Ferrari SM; Marchi S; De Bortoli N; Ruffilli I; Antonelli A
Endocrine; 2017 Jul; 57(1):175-178. PubMed ID: 27577569
[No Abstract] [Full Text] [Related]
17. Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients.
Benvenga S
J Clin Transl Endocrinol; 2019 Dec; 18():100204. PubMed ID: 31844631
[TBL] [Abstract][Full Text] [Related]
18. Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism.
Brancato D; Scorsone A; Saura G; Ferrara L; Di Noto A; Aiello V; Fleres M; Provenzano V
Endocr Pract; 2014 Jul; 20(7):657-62. PubMed ID: 24449674
[TBL] [Abstract][Full Text] [Related]
19. [Hypothyroidism-when and how to treat?].
Koehler VF; Reincke M; Spitzweg C
Internist (Berl); 2018 Jul; 59(7):644-653. PubMed ID: 29872890
[TBL] [Abstract][Full Text] [Related]
20. Treatment of congenital hypothyroidism: comparison between L-thyroxine oral solution and tablet formulations up to 3 years of age.
Vigone MC; Ortolano R; Vincenzi G; Pozzi C; Ratti M; Assirelli V; Vissani S; Cavarzere P; Mussa A; Gastaldi R; Di Mase R; Salerno M; Street ME; Trombatore J; Weber G; Cassio A
Eur J Endocrinol; 2021 Nov; 186(1):45-52. PubMed ID: 34714772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]